These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28778444)

  • 1. Tumor necrosis factor-alpha -863C/A polymorphism is associated with Guillain-Barré syndrome in Bangladesh.
    Jahan I; Ahammad RU; Farzana KS; Khalid MM; Islam MB; Rahman MI; Nahar S; Kabir Y; Mohmmad QD; Islam Z
    J Neuroimmunol; 2017 Sep; 310():46-50. PubMed ID: 28778444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between tumor necrosis factor-α gene polymorphisms and the risk of Guillain-Barré syndrome and its subtypes: A systematic review and meta-analysis.
    Liu J; Lian Z; Chen H; Shi Z; Feng H; Du Q; Zhang Q; Zhou H
    J Neuroimmunol; 2017 Dec; 313():25-33. PubMed ID: 29153605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barré syndrome.
    Islam Z; Jahan I; Ahammad RU; Shahnaij M; Nahar S; Mohammad QD
    PLoS One; 2018; 13(2):e0192703. PubMed ID: 29432441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor-4 299Gly allele is associated with Guillain-Barré syndrome in Bangladesh.
    Jahan I; Ahammad RU; Khalid MM; Rahman MI; Hayat S; Islam B; Mohammad QD; Islam Z
    Ann Clin Transl Neurol; 2019 Apr; 6(4):708-715. PubMed ID: 31019995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1A and CD1E gene polymorphisms are not associated with susceptibility to Guillain-Barré syndrome in the Bangladeshi population.
    Rahman MI; Jahan I; Khalid MM; Jahan I; Ahammad RU; Nahar S; Islam Z
    J Neuroimmunol; 2018 Jan; 314():8-12. PubMed ID: 29301656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association between FCGR2A and FCGR3A polymorphisms in Guillain-Barré Syndrome in a Brazilian population.
    Dourado ME; Ferreira LC; Freire-Neto FP; Jeronimo SM
    J Neuroimmunol; 2016 Sep; 298():160-4. PubMed ID: 27609290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of tumor necrosis factor polymorphisms with Guillain-Barré syndrome.
    Zhang J; Dong H; Li B; Li CY; Guo L
    Eur Neurol; 2007; 58(1):21-5. PubMed ID: 17483581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha 308 G/A polymorphism and Guillain-Barré syndrome risk.
    Jiao H; Wang W; Wang H; Wu Y; Wang L
    Mol Biol Rep; 2012 Feb; 39(2):1537-40. PubMed ID: 21604171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha polymorphisms and expression in Guillain-Barré syndrome.
    Prasad KN; Nyati KK; Verma A; Rizwan A; Paliwal VK
    Hum Immunol; 2010 Sep; 71(9):905-10. PubMed ID: 20600447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide oligomerization domain polymorphism confers no risk to Guillain-Barré syndrome.
    Hayat S; Asad A; Hasan I; Jahan I; Papri N; Howlader ZH; Islam Z
    Acta Neurol Scand; 2022 Aug; 146(2):177-185. PubMed ID: 35652365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to Guillain-Barré syndrome is not associated with CD1A and CD1E gene polymorphisms.
    Kuijf ML; Geleijns K; Ennaji N; van Rijs W; van Doorn PA; Jacobs BC
    J Neuroimmunol; 2008 Dec; 205(1-2):110-2. PubMed ID: 18838176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of macrophage-mediators in Guillain-Barré syndrome.
    Geleijns K; Emonts M; Laman JD; van Rijs W; van Doorn PA; Hermans PW; Jacobs BC
    J Neuroimmunol; 2007 Oct; 190(1-2):127-30. PubMed ID: 17761309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome.
    Das A; Khurshid S; Hayat S; Ahmed R; Islam Z
    J Neuroimmunol; 2020 Nov; 348():577388. PubMed ID: 32949992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.
    Caporale CM; Papola F; Fioroni MA; Aureli A; Giovannini A; Notturno F; Adorno D; Caporale V; Uncini A
    J Neuroimmunol; 2006 Aug; 177(1-2):112-8. PubMed ID: 16820217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barré syndrome in Northern Indian population.
    Nyati KK; Prasad KN; Verma A; Singh AK; Rizwan A; Sinha S; Paliwal VK; Pradhan S
    J Neuroimmunol; 2010 Jan; 218(1-2):116-9. PubMed ID: 19913922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of matrix metalloproteinase-9 polymorphism with severity of Guillain-Barré syndrome.
    Hayat S; Ahmad O; Mahmud I; Howlader MZH; Islam Z
    J Neurol Sci; 2020 Aug; 415():116908. PubMed ID: 32447054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in exon 2 of CD1 genes are associated with susceptibility to Guillain-Barré syndrome.
    Liu H; Xing Y; Guo Y; Liu P; Zhang H; Xue B; Shou J; Qian J; Peng J; Wang R; Gao Y; Fang S
    J Neurol Sci; 2016 Oct; 369():39-42. PubMed ID: 27653862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.
    Geleijns K; Laman JD; van Rijs W; Tio-Gillen AP; Hintzen RQ; van Doorn PA; Jacobs BC
    J Neuroimmunol; 2005 Apr; 161(1-2):183-9. PubMed ID: 15748958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of TNFA promoter region haplotype in Behçet's Disease.
    Park K; Kim N; Nam J; Bang D; Lee ES
    J Korean Med Sci; 2006 Aug; 21(4):596-601. PubMed ID: 16891799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 promoter polymorphisms and haplotypes in patients with Guillain-Barré syndrome.
    Hayat S; Asad A; Munni MA; Nayeem MAJ; Mostafa MG; Jahan I; Howlader MZH; Mohammad QD; Islam Z
    Ann Clin Transl Neurol; 2024 Jan; 11(1):133-142. PubMed ID: 37955408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.